Hatice Yılmaz (Hatice Yilmaz)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Metastatic Breast Cancer

Metastatic Renal Cell Carcinoma

Top Venues

Future oncology (London, England)

Biomarkers in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hatice Yılmaz, Büsra Nigdelioglu, Ali Aytac, Merve Turan, Esin Oktay, Ozlem Yersal, Sabri Barutca
The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors. Future oncology (London, England) 18 (27) (2022)
Hatice Yılmaz, Ali Yılmaz, Güzin Demirağ
Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer. Future oncology (London, England) 17 (29) (2021)
Ali Yılmaz, Hatice Yılmaz, Salim Başol Tekin, Mehmet Bilici
The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer. Biomarkers in medicine 14 (9) (2020)